Literature DB >> 11329144

The chromosome 9q genes TGFBR1, TSC1, and ZNF189 are rarely mutated in bladder cancer.

A A van Tilborg1, A de Vries, E C Zwarthoff.   

Abstract

This study assessed a series of bladder tumours and bladder tumour cell lines for sequence variation in the Krüppel-like zinc finger gene ZNF189, the tuberous sclerosis complex gene 1 (TSC1), and the TGF beta receptor type I (TGFBR1). All three genes have been mapped to 9q regions commonly deleted in transitional cell carcinoma of the bladder. Mutation analysis of the coding sequence of these genes revealed several variant bands that were shown to represent polymorphisms. Mutation analysis of the ZNF189 gene in bladder cancer cell lines identified one amino acid substitution (lysine-->isoleucine) at position 323 in exon 4. For the TSC1 gene, two mutations were identified in two out of 27 independent cell lines. Both mutations result in a truncated protein. Furthermore, one out of 36 bladder tumours had a frameshift mutation in exon 7 of the TSC1 gene. No tumour-specific mutations were found in the TGFBR1 gene. The length of the polyalanine tract present in exon 1 of the TGFBR1 gene was also investigated. It has been suggested that the allele with six alanines (6A) is more frequent in patients with bladder and other cancers, so bladder cancer patients were compared with normal controls. In both groups, the percentage of heterozygotes was 17%. These data do not support a role for the 6A allele in bladder cancer susceptibility. Copyright 2001 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11329144     DOI: 10.1002/path.860

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  5 in total

1.  Debate about TGFBR1 and the susceptibility to colorectal cancer.

Authors:  Laura Valle
Journal:  World J Gastrointest Oncol       Date:  2012-01-15

2.  TGFBR1*6A/9A polymorphism and cancer risk: a meta-analysis of 13,662 cases and 14,147 controls.

Authors:  Ru-Yan Liao; Chen Mao; Li-Xin Qiu; Hong Ding; Qing Chen; Hai-Feng Pan
Journal:  Mol Biol Rep       Date:  2009-11-01       Impact factor: 2.316

Review 3.  TGF-beta signaling alterations and susceptibility to colorectal cancer.

Authors:  Yanfei Xu; Boris Pasche
Journal:  Hum Mol Genet       Date:  2007-04-15       Impact factor: 6.150

4.  TGFB1 and TGFBR1 polymorphic variants in relationship to bladder cancer risk and prognosis.

Authors:  Adela Castillejo; Nathaniel Rothman; Cristiane Murta-Nascimento; Núria Malats; Montserrat García-Closas; Angeles Gómez-Martínez; Josep Lloreta; Adonina Tardón; Consol Serra; Reina García-Closas; Stephen Chanock; Debra T Silverman; Mustafa Dosemeci; Manolis Kogevinas; Alfredo Carrato; José Luis Soto; Francisco X Real
Journal:  Int J Cancer       Date:  2009-02-01       Impact factor: 7.396

Review 5.  Association between TGFBR1 polymorphisms and cancer risk: a meta-analysis of 35 case-control studies.

Authors:  Yong-qiang Wang; Xiao-wei Qi; Fan Wang; Jun Jiang; Qiao-nan Guo
Journal:  PLoS One       Date:  2012-08-08       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.